Weight & Metabolic

A triple agonist of the GLP-1, GIP, and glucagon receptors, studied for appetite control, energy use, and substantial weight-loss research.

What to expect: Appetite usually drops, portions get smaller, and weight can come off steadily over a cycle as the dose is increased, with possible nausea or stomach upset during the first weeks.

A dual GIP and GLP-1 receptor agonist studied in clinical research for its effects on appetite signaling, glycemic control, and weight management.

What to expect: Hunger usually fades, portions get smaller, and weight comes off slowly over weeks, with some people getting mild nausea when the dose increases.

A GH-releasing peptide known for a strong hunger signal along with the GH pulse.

What to expect: Appetite can jump fast after a dose. Sleep and recovery may improve, but hunger is the first thing most people notice.

Recombinant somatropin, the intact growth hormone used in approved deficiency treatment and studied for body composition.

What to expect: Sleep, recovery, and lean mass can improve more clearly than with secretagogues, with more water retention and acne risk.

A long-acting GLP-1 receptor agonist studied for appetite control, blood sugar regulation, and weight-loss research.

What to expect: Hunger usually fades, meals get smaller, and weight comes off gradually over months, with nausea or stomach upset most common while the dose is going up.

A long-acting amylin analogue investigated in clinical research for appetite regulation and weight management, often studied alongside GLP-1 agonists.

What to expect: Meals feel satisfying sooner, snacking drops, and weight loss is gradual, with possible mild nausea while your stomach adjusts.

A GH-releasing peptide that raises growth hormone pulses and often hunger.

What to expect: Sleep and recovery can improve, with a clear appetite bump after the shot. Hunger is stronger than with ipamorelin.

A growth hormone releasing hormone analogue studied for visceral fat reduction, GH signaling, and body-composition research.

What to expect: Midsection fat may drop gradually as GH rises, with better sleep and recovery and some water retention.

A mitochondrial peptide studied for metabolic flexibility, exercise-related signaling, and energy use.

What to expect: Workouts and all-day energy can feel a bit more efficient, with modest body-composition support over time.

A modified HGH fragment studied for fat-metabolism research without the full growth effects of intact HGH.

What to expect: Appetite and scale changes are usually mild. Think slight help with fat use, not a GLP-level drop.